In five male subjects, and a total of 15 man-nights, oxygen consumption rate (V(02)) was related to stage of sleep, as defined by electroencephalograms. Gross periodic variations which paralleled change in stage of sleep were discernible in analogue metabolic records. Computations revealed significant differences (P <.01) between all stages with V(02) highest in stage I REM (dreaming sleep), least in stages III and IV (deep sleep), and intermediate in stage II (light sleep).
Experiments were undertaken to define the relationships between body movements and changes in oxygen consumption rate (V̇O2) and pulse rate. Methods included the use of indirect calorimetry for determination of V̇O2, a bedspring transducer and multiple electromyographic leads for movements, electrocardiograms for pulse rate, and electroencephalographic (EEG) recordings for condition of wakefulness or stage of sleep. Major and minor movements were distinguishable from each other in wakeful subjects by their effects on V̇O2 and pulse rate. Both types of movements evoked shorter changes during sleep. The concurrence of muscle potential or artifact on the EEG leads and polygraphic deflection from the bedspring was found to be a reliable indicator of movements eliciting such changes. Movements in sleep which evoked measureable changes in V̇O2 were noted to involve a considerable proportion of total muscle mass. V̇O2 response to movements during sleep endured for 1.52 min (S.D. ± 0.60), compared to 3.34 min (S.D. ± 0.99) in wakeful subjects. Pulse rate response was 0.26 min (S.D. ± 0.13) in wakeful subjects and appeared to be far briefer during sleep.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.